BANK OF MONTREAL /CAN/ - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$3,066,000
-15.2%
593,007
-5.2%
0.00%
-50.0%
Q2 2021$3,614,000
+140.6%
625,276
+84.4%
0.00%
+100.0%
Q1 2021$1,502,000
+28.0%
339,121
-0.3%
0.00%0.0%
Q4 2020$1,173,000
+35.3%
340,114
+22.1%
0.00%0.0%
Q3 2020$867,000
-42.2%
278,610
-6.8%
0.00%0.0%
Q2 2020$1,500,000
+167.4%
298,862
+92.8%
0.00%0.0%
Q1 2020$561,000
-4.6%
155,016
-1.2%
0.00%
Q4 2019$588,000
+716.7%
156,897
+1065.4%
0.00%
Q3 2019$72,000
+44.0%
13,463
+3.9%
0.00%
Q2 2019$50,000
+92.3%
12,953
+159.1%
0.00%
Q1 2019$26,000
+100.0%
5,000
-21.4%
0.00%
Q4 2018$13,000
-40.9%
6,361
+12.3%
0.00%
Q3 2018$22,000
+22.2%
5,666
-0.3%
0.00%
Q2 2018$18,000
+50.0%
5,685
+13.7%
0.00%
Q1 2018$12,000
+1100.0%
5,000
+400.0%
0.00%
Q4 2016$1,0000.0%1,0000.0%0.00%
Q3 2016$1,0000.0%1,0000.0%0.00%
Q2 2016$1,000
-66.7%
1,000
-60.0%
0.00%
Q1 2016$3,000
-50.0%
2,5000.0%0.00%
Q4 2015$6,000
-25.0%
2,5000.0%0.00%
Q3 2015$8,000
+33.3%
2,500
+66.7%
0.00%
Q2 2015$6,0000.0%1,5000.0%0.00%
Q1 2015$6,000
+50.0%
1,5000.0%0.00%
Q4 2014$4,000
-20.0%
1,5000.0%0.00%
Q3 2014$5,000
+25.0%
1,5000.0%0.00%
Q2 2014$4,000
+33.3%
1,5000.0%0.00%
Q1 2014$3,0000.0%1,5000.0%0.00%
Q4 2013$3,0001,5000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders